Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi
कॉल सेंटर:  011-26589142

Research

PAPERS PUBLISHED IN JOURNALS in 2021-2022  

  1. Sahoo D, Seth R, Chaudhry R, Naranje P, Ahuja V, Dwivedi SN, Gupta AK, Meena JP. Outcome and Determinants of Neutropenic Enterocolitis in Pediatric Cancer Patients. J Pediatr Hematol Oncol. 2022 Apr 22. doi: 10.1097/MPH.0000000000002422. Epub ahead of print. PMID: 35446793.  
  2. Sachan S, Chaudhry R, Pathania S, Suvirya S, Verma P, Reddy HD, Malhotra KP, Vinayaraj EV. Coexistence of primary erythema migrans and erythema multiforme in early Lyme disease. Indian J Dermatol Venereol Leprol. 2022 Mar 29:1-3. doi: 10.25259/IJDVL_53_2021. Epub ahead of print. PMID: 35389014.  
  3. Bamola VD, Kapardar R, Lal B, Sharma A, Chaudhry R. A metagenomic assessment of gut microbiota in Indian colon cancer patients. J Cancer Res Ther. 2022 Jan-Mar;18(1):96-102. doi: 10.4103/0973-1482.341139. PMID: 35381769.  
  4. Chaudhry R, Sharma N, Bahadur T, Khullar S, Agarwal SK, Gahlowt A, Gupta N, Kumar L, Kabra SK, Dey AB. Molecular characterization of Clostridioides difficile by multi-locus sequence typing (MLST): A study from tertiary care center in India. Anaerobe. 2022 Mar 9:102545. doi: 10.1016/j.Anaerobe.2022.102545. Epub ahead of print. PMID: 35278711.  
  5. Singh A, Singh AN, Rathor N, Chaudhry R, Singh SK, Nath G. Evaluation of Bacteriophage Cocktail on Septicemia Caused by Colistin-Resistant Klebsiella pneumoniae in Mice Model. Front Pharmacol. 2022 Feb 7;13:778676. doi: 10.3389/fphar.2022.778676. PMID: 35197852; PMCID: PMC8860340.  
  6. Rathor N, Sachdeva P, Chaudhry R. Genome Sequence of Bacteriophage Infecting a Rare Pathogen, Pseudomonas luteola. Microbiol Resour Announc. 2022 Feb 17;11(2):e0111321. doi: 10.1128/mra.01113-21. Epub 2022 Feb 17. PMID: 35175114; PMCID: PMC8852300.  
  7. Nisha R, Chaudhry R. Bacteriophages as Surrogate Marker for Inactivation of SARS-CoV-2 by Ultraviolet Radiation to Prevent COVID-19 Transmission. J Glob Infect Dis. 2021 Nov 23;13(4):199-200. doi: 10.4103/jgid.jgid_230_21. PMID: 35017882; PMCID: PMC8697820.  
  8. Sinha AP, Gupta SS, Poluru R, Raut AV, Arora NK, Pandey RM, Sahu AR, Bethou A,  Sazawal S, Parida S, Bavdekar A, Saili A, Gaind R, Kapil A, Garg BS, Maliye C, Jain M, Mahajan KS, Dhingra P, Pradhan KC, Kawade AS, Nangia S, Mukherjee A, Rasaily R, Sharma RS,  the ProSPoNS study Group.   Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0–2-month-old low birth weight infants in India—the “ProSPoNS” Study protocol for a phase III, multicentric, randomized, double-blind, placebo-controlled trial. Trials. 2021; 22: 242.   
  9. Avershina E, Sharma P, Taxt AM, Singh H, Frye SA, Paul K, Kapil A, Naseer U, Kaur P, Ahmad R. AMR-Diag: Neural network based genotype-to-phenotype prediction of resistance towards β-lactams in Escherichia coli and Klebsiella pneumoniae. Comput Struct Biotechnol J. 2021; 19: 1896–1906. doi: 10.1016/j.csbj.2021.03.027.  
  10. Kapil A. Judicious Antibiotic Use in Community Acquired Staphylococcal Infections. The Indian Journal of Pediatrics 2021, 88(2):109–110  
  11. Mirdha BR. Evolving Patterns of Cryptosporidiosis: Issues and Implications in the Context of Public Health in India .Ann NatlAcad Med Sci (India) 2021;57:81–93.  
  12. Mirdha BR.  Dihydropteraote synthase (DHPS) gene mutation in human pneumocystosis. J AIDS HIV Treatment2021;. 3(1): 17-20.  
  13. Malhotra S, Singh S, Mala R, Sood S. Aptamer selection: Choosing the appropriate SELEX. Ind. J. Pure App. Biosci. 2021; 9(2):240-253.  
  14. Kumar A, Mohapatra S, Bir R, Tyagi S, Bakhshi S, Mahapatra M, et al. Intestinal Colonization Due to Carbapenem-Resistant Enterobacteriaceae Among Hematological Malignancy Patients in India: Prevalence and Molecular Characterisation. Indian J. Hematol Blood Transfus. 2021;Doi: 10.1007/s12288-021-01415-y.  
  15. Mahajan N, Sood S, Das BK, Kapil A, Sreenivas V, Kar HK et al. Molecular characterization of decreased susceptibility (DS) to ceftriaxone and genotyping of Neisseria gonorrheae isolates in New Delhi, India. Diag. Microbiol. Inf. Dis. 2021; 101(1): 115423.  
  16. Tanvi Dev, Mahajan N, Sood S, Gupta S. The ping-pong infection in gonorrhea: Lest we forget. Ind. J. Dermatol. Venereol Leprol. 2021;88(1):109-111.  
  17. Yadav D, Singh S, Dhawan B, Sood S, Gupta S. Laboratory detection of bacterial pathogens and clinical and laboratory response of syndromic management in patients with cervical discharge: a retrospective study. Ind. J. Dermatol. Venereol. Leprol. 2021;27:1-5.  
  18. Challa A, Sood S, Kachhawa G, Upadhyay A, Dwivedi S, Gupta S. Diagnostic concordance between Amsel’s criteria and Nugent scoring method in the assessment of bacterial vaginosis. Sexual Health. 2021;Doi: 10.1071/SH21149.  
  19. Ahmed J, Singh G, Mohan A, Agarwal R, Sachdev J, Khullar S, …Xess I, et  al.  Invasive pulmonary aspergillosis infection in severely ill COPD patients in pulmonary ward and ICU. Indian J Med Microbiol. 2022 Mar 12:S0255-0857(22)00042-1. doi: 10.1016/j.ijmmb.2022.02.006. Epub ahead of print.  
  20. Ahmed J, Singh G, Xess I, Pandey M, Mohan A, Sachdev J, et  al. Emerging Aspergillus lentulus infections in India. Indian J Med Microbiol. 2021. Nov 15:S0255-0857(21)04701-0.  
  21. Ahmed NH, Xess I, Singh G, Satpathy G, Sharma N, Agarwal T, etal. Species identification, antifungal susceptibility profiles and biofilm formation attributes of Rhodotorula isolates from ocular infections. Mycoses. 2021;64(10):1183-1196.  
  22. Arora U, Priyadarshi M, Katiyar V, Soneja M, Garg P, Gupta I, ....Singh G, Xess I,et  al.Risk factors for Coronavirus disease-associated mucormycosis. J Infect. 2022 ;84(3):383-390.  
  23. Dabas Y, Mohan A, Xess I. Prognostic Scores and Azole-Resistant Aspergillus fumigatus in Invasive Aspergillosis from an Indian Respiratory Medicine ICU (ICU Patients with IA Suspicion). J Fungi (Basel). 2021 Nov 20;7(11):991.  
  24. Dabas Y, Xess I, Pandey M, Ahmed J, Sachdev J, Iram A, ....Singh G, et  al. Epidemiology and Antifungal Susceptibility Patterns of Invasive Fungal Infections (IFIs) in India: A Prospective Observational Study. J Fungi (Basel). 2021 Dec 30;8(1):33.  
  25. Duggal R, Goswami R, Xess I, Duggal I, Talwar A, Mathur VP. Prevalence of species-specific candidiasis and status of oral hygiene and dentition among diabetic patients: A hospital-based study. Indian J Dent Res. 2021 Jul- Sep;32(3):292-298. doi: 10.4103/ijdr.IJDR_827_20.  
  26. Keri VC, Kumar A, Singh G, Mandal A, Ali H, Ranjan P, et al. Pilot study on burden of fungal contamination in face masks: need for better mask hygiene in the COVID-19 era. Infez Med. 2021 Dec 10;29(4):557-561.  
  27. Keri VC, Kumar A, Singh G, Xess I, Khan MA, Rastogi N, etal. Fungal carriage on healthcare workers' hands, clothing, stethoscopes and electronic devices during routine patient care: a study from a tertiary care center. J Prev Med Hyg. 2021 Apr 29;62(1):E170-E173.  
  28. Patel A, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R,…Singh G; MucoCovi Network3. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India. Emerg Infect Dis. 2021 Sep;27(9):2349-2359.  
  29. Ray A, Chowdhury M, Sachdev J, Sethi P, Meena VP, Singh G, …Xess I, et  al. Efficacy of LD Bio Aspergillus ICT Lateral Flow Assay for Serodiagnosis of Chronic Pulmonary Aspergillosis. J Fungi (Basel). 2022 Apr 14;8(4):400.  
  30. Ray A, Manikanta J, Singh K, Gabra P, Vyas S, Singh G, …Xess I, etal. An open-label non-inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma. Mycoses. 2021 Sep;64(9):1038-1044.  
  31. Saluja G, Bhari A, Pushker N, Agrawal S, Meel R, Thakar A, …Xess I, et  al. Experience on rhino-orbital mucormycosis from a tertiary care hospital in the first wave of COVID-19: An Indian perspective. Med J Armed Forces India. 2022 Apr 2. doi: 10.1016/j.mjafi.2022.01.009. Epub ahead of print.  
  32. Singh K, Siddharth V, Singh G. Mechanized laundering of mops for floor cleaning can reduce infection transmission through hospital floor. Indian J Med Microbiol. 2021 Apr;39(2):224-227.  
  33. Swain S, Ray A, Sarda R, Vyas S, Singh G, Jorwal P, …Xess I,et  al.COVID-19-associated subacute invasive pulmonary aspergillosis. Mycoses. 2022 Jan;65(1):57-64.  
  34. Verma P, Sikka K, Verma H, Thakar A, Mitra DK, Saurabh A, …Singh Get  al.Intracellular cytokine expression in invasive fungal sinusitis and its impact on patient outcome. J Laryngol Otol. 2022 Mar 2:1-23.  
  35. Verma KK, Senthilnathan G, Bhatia S, Xess I, Gupta V, Dwivedi SN, et al. Oral Isotretinoin Combined with Oral Terbinafine Versus Oral Terbinafine Alone to Treat Recurrent Dermatophytosis: An Open-Label Randomised Clinical Trial. Indian Dermatol Online J. 2021 Nov 22;12(6):820-825.  
  36. Xess I, Singh G, Yadav RK, Pandey M, Sachdev J. COVID-19 Associated Mucormycosis: Ramping up our services during crisis. Indian J Med Microbiol. 2022 Apr 1:S0255-0857(22)00052-4.  
  37. Sreenath K, Batra P, Vinayaraj EV, Bhatia R, SaiKiran K, Singh V, Singh S, Verma N, Singh UB, Mohan A, Bhatnagar S, Trikha A, Guleria R, Chaudhry R. Coinfections with Other Respiratory Pathogens among Patients with COVID-19. Microbiol Spectr. 2021 Sep 3;9(1):e0016321. doi:10.1128/Spectrum.00163-21. Epub 2021 Jul 21.  
  38. Chaudhry R, Sreenath K, Batra P, Vinayaraj EV, Rathor N, Saikiran K, Aravindan A, Singh V, Brijwal M, Soneja M, Verma N, Subramanium R, Singh UB, Guleria R. Atypical bacterial co-infections among patients with COVID-19: A study from India. J Med Virol. 2022 Jan;94(1):303-309.  
  39. Chaudhry R, Bahadur T, Sagar T, Agrawal SK, Arif N, Choudhary SK, Verma N. Infective Endocarditis Caused by C. sordellii: The First Case Report from India. J Lab Physicians. 2021 Mar;13(1):74-76.   
  40. Kumar V, Surve A, Biswal D, Verma N, Kashyap S, Venkatesh P, Mirdha BR. Intra-ocular hydatid cyst in a child: A rare presentation. Eur J Ophthalmol. 2022 Feb 15:11206721221079481. doi: 10.1177/11206721221079481. Epub ahead of print.  
  41. SaiKiran KVP, Biswal D, Agrawal SK, Batra P, Sagar T, Choudhary SK, Verma N, Chaudhry R. Anaerobes in cardiac infections: A decade experience from the tertiary care center. Indian J Med Microbiol. 2022 Jan 11:S0255-0857(21)04733-2. doi: 10.1016/j.ijmmb.2021.12.013. Epub ahead of print.  
  42. Yadav D, Singh S, Dhawan B, Sood S, Gupta S. Laboratory detection of bacterial pathogens and clinical and laboratory response of syndromic management in patients with cervical discharge: A retrospective study. Indian J Dermatol Venereol Leprol. 2021 Nov 27:1-5.  
  43. Raza S, Gautam H, Mohapatra S, Sood S, Dhawan B, Chaudhry R et al. Molecular characterization of resistance-nodulation-cell division efflux pump genes in multidrug-resistant Acinetobacter baumannii. J Global Infect Dis 2021 Nov 9;13(4): 177-179.
  44. Bhavna M, Gautam H,  Raza S, Mohapatra S,  Dhawan B, Kapil A, Das B. K. Detection of Aminoglycosides Modifying Enzymes (AMEs) genes and mutation in Acinetobacter baumannii isolates along with efflux pump activity. Ind J Med Microbiol 2021; 39(S):S8-S9.  
  45. Sharma N, Gautam H, Tyagi S, Raza S, Mohapatra S, Sood S, Dhawan B et al. Clinical use of Multiplex-PCR for the Diagnosis of Acute Bacterial Meningitis. J Fam Med Prim Care. 2022; 11:593-8.  
  46. Juyal D, Dhawan B, Thawani V, Thaledi S. Sexualized drug use (“chemsex”) and sexually ransmitted infections. Indian J Sex Transm Dis. 2021; 42(2):180-181.  
  47. Nityadarshini N, Mohapatra S, Gautam H, Jain V, Chaudhry R, Kapil A. Polymicrobial growth in standard urine culture: Time to Act or Ignore? Tropical Doctor. 2022; DOI: 10.1177/00494755221076909. Online ahead of print.  
  48. Mohapatra S, Panigrahy R, Tak V, Shwetha J. V., Sneha K. C., Chaudhuri S, et al.  Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India. Access Microbiology 2022 Feb 9;4(2):000321. DOI 10.1099/acmi.0.000321  
  49. Yadav M, Pundir S , Kumari R, Kumar A , Shwetha JV , Panigrahi R, et al. Variation in virulence genes as a differentiator of asymptomatic Vs symptomatic isolates: Insights from community-acquired Uropathogenic Escherichia coli. Microbiology2022;168:001161. DOI 10.1099/mic.0.001161.  
  50. Bir R, Gautam H, Arif N, Chakravarti P, Verma J, Banerjee S, et al. Analysis of Colistin resistance in Carbapenem-Resistant Enterobacterales and XDR Klebsiella pneumoniae. Ther Adv Infectious Dis 2022;9:1-15. doi.org/10.1177%2F20499361221080650.  
  51. Choudhury M, Narula J, Hote MP, Mohapatra S. Mucormycosis: An Uncommon Cutaneous Infection at Permanent Pacemaker-Implanted Site in a VeryLow-Birthweight Baby J Card Crit Care 2021;5:242–245.  
  52. Kumar A, Mohapatra S, Pius A, Sharma R, Khan MA, Kumar N, Chakrawarty A, Vishwakarma VK, Nischal N, Ranjan P, Soneja M, Wig N. Activity of Fosfomycin against the spectrum of uropathogens causing cystitis.Current Drug Therapy 2022,17:45-49.
  53. Sharma A, Kulkarni S, Thukral A, Sankar MJ, Agarwal R, Deorari AK, Mohapatra S, Velpandian T, Bajpai M. Aqueous chlorhexidine 1% versus 2% for neonatal skin antisepsis: a randomised non-inferiority trial. Arch Dis Child Fetal Neonatal Ed. 2021 Nov;106(6):643-648. doi: 10.1136/archdischild-2020-321174. Epub 2021 Jun 9.  
  54. Mantoo MR, Ghimire JJ, Mohapatra S, Shankar J. Elizabethkingia anophelis infection in an infant: an unusual presentation. BMJ Case Rep 2021;0:e243078. doi:10.1136/bcr-2021-243078.  
  55. Sahitya DSK, Jandiyal A, Jain A, Senapati J, Nanda S, Aggarwal M, Kumar P, Mohapatra S, Ray P, Malhotra P, Mahapatra M, Dhawan R. Prevention and management of carbapenem-resistant Enterobacteriaceae in haematopoietic cell transplantation. Ther Adv Infect Dis. 2021 Oct 27;8:20499361211053480. doi: 10.1177/20499361211053480.  
  56. Ghimire JJ, Jat KR, Sankar J, Lodha R, Iyer VK, Gautam H, Sood S, Kabra SK. Azithromycin for Poorly Controlled Asthma in Children: A Randomized Controlled Trial. Chest. 2022 Feb 22:S0012-3692(22)00293-8. doi: 10.1016/j.chest.2022.02.025. Epub ahead of print.  
  57. Kumari S, Gautam H, Nityadarshini N. Chaudhry R, Das BK. Online classes vs traditional classes? Comparison during COVID-19. J Edu Health Promot 2021;10:457 . DOI: 10.4103/jehp.jehp_317_21
  58. Maurya SP, Sharma A, Singh R, Gautam H, Das BK. HIV testing & diagnosis in 2020 at the apex tertiary referral hospital of India: impact of COVID-19 pandemic. AIDS Care. 2021; Sep 8:1-4. doi: 10.1080/09540121.2021.1975631. Epub ahead of print.  
  59. Singh UB, Verma Y, Jain R, Mukherjee A, Gautam H, Lodha R et al. Childhood Intra-Thoracic Tuberculosis Clinical Presentation Determines Yield of Laboratory Diagnostic Assays. Front. Pediatr. 2021; 9:667726. doi: 10.3389/fped.2021.667726   
  60. Singh UB, Rophina M, Chaudhry R, Senthivel V, Bala K, Bhoyar RC, Jolly B, Jamshed N, Imran M, Gupta R, Aggarwal P, Divakar MK, Sinha S, Arvinden VR, Bajaj A, Shamnath A, Jain A, Group CCC, Scaria V, Sivasubbu S, Guleria R. Variants of Concern responsible for SARS-CoV-2 vaccine breakthrough infections from India. J Med Virol.2021;Nov 16.doi: 10.1002/jmv.27461. Online ahead of print.
  61. Korukanti PK, Bhalla AS, Goyal A, Naranje P, Guleria R, Mohan A, Singh UB. Aspergilloma Morphology on Computed Tomography Angiography and its Clinical Impact in Patients of Haemoptysis. Curr Probl Diagn Radiol. 2022; Jan 25:S0363-0188(22)00010-X. doi: 10.1067/j.cpradiol.2022.01.009. Epub ahead of print.  
  62. Thakur CK, Batra P, Vinayaraj EV, Sreenath K, Rathor N, Singh UB, Bhatia R, Aravindan A, Wig N, Guleria R, Chaudhry R. Scrub typhus in two COVID-19 patients: a diagnostic dilemma. Future Microbiol. 2022 Feb;17(3):161-167. doi: 10.2217/fmb-2021-0163. Epub 2022; Jan 19. PMID: 35044234;  
  63. Kafle G, Garg B, Mehta N, Sharma R, Singh U, Kandasamy D, Das P, Chowdhury B. Diagnostic yield of image-guided biopsy in patients with suspected infectious spondylodiscitis : a prospective study from a tuberculosis-endemic country. Bone Joint J. 2022; Jan;104-B(1):120-126. doi: 10.1302/0301-620X.104B1.BJJ-2021-0848.R2.  
  64. Chaudhry R, Sreenath K, Batra P, Vinayaraj EV, Rathor N, Saikiran K, Aravindan A, Singh V, Brijwal M, Soneja M, Verma N, Subramanium R, Singh UB, Guleria R. Atypical bacterial co-infections among patients with COVID-19: A study from India. J Med Virol. 2022 Jan;94(1):303-309. doi: 10.1002/jmv.27324. Epub 2021 Sep 15.  
  65. Sreenath K, Batra P, Vinayaraj EV, Bhatia R, SaiKiran K, Singh V, Singh S, Verma N, Singh UB, Mohan A, Bhatnagar S, Trikha A, Guleria R, Chaudhry R. Coinfections with Other Respiratory Pathogens among Patients with COVID-19. Microbiol Spectr. 2021 Sep 3;9(1):e0016321. doi: 10.1128/Spectrum.00163-21. Epub 2021 Jul 21.  
  66. Vinayaraj EV, Gupta N, Sreenath K, Thakur CK, Gulati S, Anand V, Tripathi M, Bhatia R, Vibha D, Dash D, Soneja M, Kumar U, Padma MV, Chaudhry R. Clinical and laboratory evidence of Lyme disease in North India, 2016-2019. Travel Med Infect Dis. 2021 Sep-Oct;43:102134. doi: 10.1016/j.tmaid.2021.102134. Epub 2021 Jun 30.  
  67. Mohanty S, Chaudhry R. Emerging role of anaerobes in health and disease. Indian J Med Microbiol. 2021 Oct-Dec;39(4):402-403. doi: 10.1016/j.ijmmb.2021.06.003. Epub 2021 Jun 19.  
  68. Batra P, Soni KD, Mathur P. Efficacy of probiotics in the prevention of diarrhea in ventilated critically ill ICU patients: meta-analysis of randomized control trials: author's reply. J Intensive Care. 2021 Oct 15;9(1):61. doi: 10.1186/s40560-021-00578-0.  
  69. Sharma JB, Manchanda S, Jaiswal P, Dharmendra S, Singh U, Hari S. Computed tomographic findings in female genital tuberculosis tubo-ovarian masses. Indian J Tuberc. 2022; Jan;69(1):58-64. doi: 10.1016/j.ijtb.2021.03.001. Epub 2021 Mar 9.  
  70.  Sharma JB, Singh UB, Kriplani A, Kumar S, Roy KK, Kumari A, Dharmendra S. Hysteroscopic observations in 348 consecutive cases of female genital tuberculosis: A prospective study. Indian J Tuberc. 2022; Jan;69(1):48-57. doi: 10.1016/j.ijtb.2021.02.010. Epub 2021 Mar 9.  
  71. Iyer VK, Malhotra N, Singh UB, Gupta P, Dhaliwal L, Gainder S, Jain A, Jaiswar SP, Srikantam A, Hari A, Ahmad A, Chandhiok N. Immunohistochemical evaluation of infiltrating immune cells in endometrial biopsy of female genital tuberculosis. Eur J Obstet Gynecol Reprod Biol. 2021;Dec;267:174-178. doi: 10.1016/j.ejogrb.2021.10.031. Epub 2021 Nov 1.  
  72. Padmapriydarsini C, Mamulwar M, Mohan A, Shanmugam P, Gomathy NS, Mane A, Singh UB, Pavankumar N, Kadam A, Kumar H, Suresh C, Reddy D, Devi P, Ramesh PM, Sekar L, Jawahar S, Shandil RK, Singh M, Menon J, Guleria R; METRIF Team. Randomized trial of Metformin with Anti-tuberculosis drugs For Early Sputum Conversion in Adults with Pulmonary Tuberculosis. Clin Infect Dis. 2021; Nov 26:ciab964. doi: 10.1093/cid/ciab964. Epub ahead of print.  
  73. Gupta AK, Ramachandran M, Gupta A, Meena JP, Dwivedi T, Bala K, Kanga U, Singh U, Gupta R, Seth R. Allogeneic hematopoietic stem cell transplant after COVID-19 infection and its effect on the antibody titers to SARS-CoV-2. Pediatr Transplant. 2022;Mar;26(2):e14175. doi: 10.1111/petr.14175. Epub 2021 Oct 20.
  74. Sharma JB, Kumar R, Singh U, Kumari A, Dharmendra S, Sachani H. Pre treatment and post treatment positron emission tomography-computed tomography (PET-CT) to evaluate treatment response in tuberculous Tubo-Ovarian masses. Eur J Obstet Gynecol Reprod Biol. 2021; Sep;264:128-134. doi: 10.1016/j.ejogrb.2021.07.013. Epub 2021 Jul 16. PMID: 34303072.  
  75. Sharma JB, Khurana A, Hari S, Singh U, RituYadav, Dharmendra S. Evaluation of Role of Transabdominal and Transvaginal Ultrasound in Diagnosis of Female Genital Tuberculosis. J Hum Reprod Sci. 2021; Jul-Sep;14(3):250-259. doi: 10.4103/jhrs.jhrs_161_20. Epub 2021 Sep 28.  
  76. Bala K, Kumari S, Monga R, Sagar P, Thakar A, Sharma SC, Singh UB. Spectrum of mycobacterial pathogens responsible for head and neck tuberculosis-like presentation. Access Microbiol. 2021; Dec 17;3(12):000304.doi: 10.1099/acmi.0.000304.  
  77. Gupta AK, Ramachandran M, Gupta A, Meena JP, Dwivedi T, Bala K, Kanga U, Singh U, Gupta R, Seth R. Allogeneic hematopoietic stem cell transplant after COVID-19 infection and its effect on the antibody titers to SARS-CoV-2. Pediatr Transplant. 2022; Mar;26(2):e14175. doi: 10.1111/petr.14175. Epub 2021 Oct 20.  
  78. Bhange D, Prasad N, Singh S, Prajapati HK, Maurya SP, Gopalan BP, Nadig S, Chaturbhuj D, Jayaseelan B, Dinesha TR, Ahamed SF, Singh N, Brahmaiah A, Mehta K, Gohil Y, Balakrishnan P, Das BK, Dias M, Gangakhedkar R, Mehendale S, Paranjape RS, Saravanan S, Shet A, Solomon SS, Thakar M, Ranga U. The Evolution of Regulatory Elements in the Emerging Promoter-Variant Strains of HIV-1 Subtype C. Front Microbiol. 2021 Nov 16;12:779472. doi: 10.3389/fmicb.2021.779472.  
  79. Basu A, Biswas A, Wig N, Sood R, Soneja M, Nischal N, Das BK. Prevalence and evaluation of risk factors of anti-retroviral therapy failure among human immunodeficiency virus/acquired immune deficiency syndrome patients in North India. Trans R Soc Trop Med Hyg. 2021 Sep 3;115(9):1019-1025. doi: 10.1093/trstmh/trab008.  
  80. Kumar R, Dar L, Amarchand R, Saha S, Lafond KE, Purakayastha DR, Kumar R, Choudekar A, Gopal G, Dhakad S, Narayan VV, Wahi A, Chhokar R, Lindstrom S, Whitaker B, Choudhary A, Dey AB, Krishnan A. Incidence, risk factors, and viral etiology of community-acquired acute lower respiratory tract infection among older adults in rural north India. J Glob Health.2021;11:04027.  
  81. Krishnan A, Dar L, Saha S, Narayan VV, Kumar R, Kumar R, Amarchand R, Dhakad S, Chhokar R,  Choudekar A, Gopal G, Choudhary A, Potdar V, Chadha M, Lafond KE, Lindstrom S, Whitaker B, Widdowson M-A, Jain S.  Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial. PLoS Medicine, 18(4). 2021.  
  82. Lall M, Dar L, Bhatla N, Kumar P, Choudhary A, Mathur SP, Gupta RM. Prevalence of Human Papillomavirus (HPV) Genotypes in Cervicovaginal Secretions of HIV Positive Indian Women and Correlation With Clinico-Virological Parameters. Frontiers in Reproductive Health. (3) 2021.  
  83. Krishnan A, Dar L, Amarchand R, Prabhakaran AO, Kumar R, Rajkumar P, Kanungo S, Bhardwaj SD, Choudekar A, Potdar V, Chakrabarti AK, Kumar CPG, Parameswaran GG, Dhakad S, Manna B, Choudhary A, Lafond KE, Azziz-Baumgartner E, Sahaet S, Cohort profile: Indian Network of Population-Based Surveillance Platforms for Influenza and Other Respiratory Viruses among the Elderly (INSPIRE). BMJ Open 2021;11:e052473. doi:10.1136/ bmjopen-2021-052473.  
  84. Bajpai V, Gupta E, Choudhary A, Bajpai M. Clinical relevance of hepatitis B core (total) antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors. Asian J Transfus Sci.2021; 15(2): 259-260.  
  85. Desai D, Khan AR, Soneja M, Mittal A, Naik S, Kodan P, Mandal A, Maher GT, Kumar R, Agarwal A, Gowda NR, Vikas H, Kumar P, Pandey S, Pandey RM, Kumar A, Ray A, Jorwal P, Nischal N, Choudhary A, Brijwal M, Madan K, Lodha R, Sinha S, Dar L, Wig N, Guleria R. Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study. Published online November 23, 2021 https://doi.org/10.1016/S1473-3099(21)00674-5.  
  86. Kiro VV, Gupta A, Singh P, Sharad N, Khurana S, Prakash S, Dar L, Malhotra R, Wig N, Kumar A, Trikha A, Mathur P. Evaluation of COVID-19 antigen fluorescence immunoassay test for rapid detection of SARS-CoV-2. J Glob Infect Dis. 2021 May 31;13(2):91-93.  
  87. Panda S, Mohamed A, Sikka K, Kanodia A, Sakthivel P, Thakar A, Bhatnagar S, Mohan A, Meena VP, Tiwari P, Sahoo B, Dar L, Vig S, Garg R, Kumar C. Otolaryngologic manifestation and long-term outcome in mild COVID-19: Experience from a tertiary care centre in India. Indian J Otolaryngol Head Neck Surg. 2020 Oct 14;73(1):1-6.  
  88. Desai D, Khan AR, Soneja M, Mittal A, Naik S, Kodan P, Mandal A, Maher GT, Kumar R, Agarwal A, Gowda NR, Vikas H, Kumar P, Pandey S, Pandey RM, Kumar A, Ray A, Jorwal P, Nischal N, Choudhary A, Brijwal M, Madan K, Lodha R, Sinha S, Dar L, Wig N, Guleria R. Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study. Published online November 23, 2021 https://doi.org/10.1016/S1473-3099(21)00674-5.  
  89. Vidyarthi AJ, Das A, Chaudhry R. Antimicrobial resistance and COVID-19 syndemic: Impact on public– health. Drug Discov Ther. 2021;15(3):124-12  
  90. Vidyarthi AJ, Das A, Chaudhry R. Mucormycosis and black fungus: Breaking the myth. Maturitas.2022; 159:69-70.  
  91. Elavarasi A, Raju Sagiraju HK, Garg RK, Ratre B, Sirohiya P, Gupta N,…….. , Vidyarthi AJ, Chaudhry R, Das A, et al. Clinical features, demography, and predictors of outcomes of SARS-CoV-2 infection at a tertiary care hospital in India: A cohort study. Lung India. 2022; 39(1):16-26.

              Title of the running projects 2021-22

S. No

 

1.

Bacteriophage endolysins: An alternative strategy for MDR Acinetobacter spp.

2.

Clinical and Epidemiological study of Lyme disease: A multi-centric task force study in India (Indian Council of Medical Research (ICMR) a multi-centric task force study)

3.

Seroepidemiological study of Rickettsia and Scrub typhus among patients with acute febrile illness and molecular detection by Real time PCR.

4.

Identification of possible co-infections in COVID-19, and its impact on patient outcomes

5.

To determine gut colonization of Clostridiodes difficile, Vancomycin resistant Enterococci and Carbapenem Resistant Enterobacteriaceae in recovered COVID cases.

6.

Nodal Center for National surveillance of Antimicrobial resistance  

7.

National Surveillance System for Enteric Fever in India (NSSEFI)- Tier 3 

8.

Development of Novel Method for Rapid Pathogen Culture to Facilitate their Identification and Antimicrobial Susceptibility Testing. 

9.

Evaluation of NF- κB based reactivation of latency in HIV infected individuals who are on antiretroviral therapy for more than 15 years: A Quest for Cure

10.

Evaluation of role of B-1 cells in modulating the response of T cells in HIV infected patients pre and post antiretroviral therapy: cohort study.

11.

Evaluating immune mechanisms in individual with Mycormycosis in COVID-19 infected patients

12.

A multi-centric observational study to examine replicative fitness and pathogenic properties of the emerging new viral strains of HIV-1 in India

13.

Evaluating immune mechanism leading to carrier stage in typhoid infection among Indian Population; prospective cohort study

14.

External Quality Assurance Scheme (EQAS) of National HIV/AIDS Reference Laboratory, AIIMS, Delhi

15.

HIV integrated counselling and testing and CD4 testing programme

16.

Streptococcus pneumoniae and Hemophilus serotype distribution and antibiotic resistance in isolates from pediatric pneumonia cases in Assam

17.

Study of immune-pathogenesis and disease dynamics of Pneumocystis jirovecii pneumonia (Penumocystis pneumonia )

18.

ICMRs: Advanced Mycology Diagnostic and Research Centre (AMDRC)

19.

Development of superhydrophobic catheter to inhibit bacterial and yeast growth

20.

Diagnosis of Invasive mucormycosis in COVID patients using conventional and molecular methods.

21.

Effectiveness of bundled intervention in surgical site infections among patients undergoing clean orthopedic surgeries with hardware implants: A randomized controlled trial”

22.

Multi-centric study on prevalence of Mycoplasma genitalium and its resistance markers in the high–risk group (MSM and FSW) attending sexually transmitted disease clinics in North India.

23.

 

Mapping hotspots of MDR-TB in Assam, Sikkim and Tripura using Genomics approaches 

24.

Early Bactericidal Activity (EBA) of Rifampicin and Feropenem in Tuberculosis (Rifampicin Susceptible)

25.

Early Bactericidal Activity (EBA) and Pk/Pd Study of Rifampicin Feropenem Cefdinir with Clavulanate vs Standard of Care in Newly Diagnosed Smear Positive Rifampicin Susceptible TB

26.

Epidemiological impact and intersection of the COVID-19 and Tuberculosis Pandemics in Brazil, Russia, India and South Africa

27.

Validation of Indigenously Developed Diagnostic kit based on Detection of Proteomic markers from Urine for Diagnosis of Pulmonary and Extra-pulmonary Tuberculosis

28.

Development of Surface Plasmon Resonance Array Biosensor for Rapid Molecular Drug Resistance Detection for MDR and XDR TB

29.

Crohn’s Disease in India: A multicentre study from country where intestinal tuberculosis as well as Johne’s disease in endemic

30.

 

Diagnosis Of Pulmonary and Extra Pulmonary Tuberculosis Patients Using Differently Expressed Proteins as Potential Biomarkers. Approach towards Development of Point of Care Test.

31.

Rapid Molecular Drug Resistance Detections for MDR and XDR-TB and Molecular Typing of Mycobacterium Tuberculosis From Ziehl-Neelsen’s Stained Microscopic Slides From Delhi State.

32.

Studies on halophilic/ haloalkaliphilic actinomycetes and bacteria from hypersaline habitat as potential source of antibacterial molecules for drug resistant microbes

33.

Towards point of care test development for Bacterial Vaginosis, a polymicrobial infection

34.

Comparison of diagnostic accuracy of Real time PCR versus Nugent’s scoring in Indian women with and without Bacterial Vaginosis (BV).

35.

 

Emerging drug resistance in community acquired urinary tract infection and molecular insights into dynamics of resistant traits in Indian isolates- A pan-India multi-centric cross-sectional study

37.

Efficacy of cold atmospheric plasma jet for its antimicrobial activity against drug resistant bacterial and fungal pathogen: An in-vitro and in-vivo study

38.

Development of super hydrophobic catheters to inhibit bacterial and yeast growth

39.

Active surface modification strategies to inhibit biofilm formation and bacterial infections

40.

Platform for discovery of novel therapeutic monoclonal antibodies against MDR and XDR Klebsiella pneumoniae

41.

In vitro susceptibility of Cefiderocol against carbapenem-resistant gram-negative bacilli from patients with blood stream infection/sepsis, urinary tract infection or pneumonia

42.

Implementation of An Institutional Antifungal Stewardship Program (AFSP) On The Appropriate Use Of Antifungal Therapy And Outcomes In Patients With Invasive Fungal Infections.

43.

Study of hyaline non-sporulating moulds isolated from clinical samples of tertiary care respiratory hospital in Delhi

44.

Molecular Epidemiology and In-Vitro Antifungal Susceptibility of Cryptic Aspergillus species from Clinical and Environment samples

45.

Molecular characterization, biofilm formation, in vitro antifungal susceptibility of Mucorales causing COVID associated Mucormycosis (CAM).

46.

Efficacy of cold atmospheric plasma jet for its antimicrobial activity against drug resistant bacterial and fungal pathogen: An in-vitro and in-vivo study.

47.

Genomic profiling of invasive and hospital acquired Escherichia coli pathotypes from different clinical samples to identify the virulence and antimicrobial resistance markers

48.

Biomarkers for bacteremia, antimicrobial resistance and hospital acquired infections by NMR and Mass Spectrometry among febrile neutropenic patients”

49.

In vitro susceptibility of Plazomicin in clinical isolates of Enterobacteriaceae and its correlation with Aminoglycoside modifying enzyme resistance mechanism.

50.

Post exposure effect of COVID-19 infection on Nuclear factor kappa B (NF-кB) activity in immune cells: friend or foe in long term complications?

51.

Magnitude of asymptomatic malaria infections in pregnant women in a community hospital

52.

Point of care Urinary Lipoarabinomannan antigen (LAM) detection as a diagnostic tool for Extra-pulmonary tuberculosis.

53.

Changing epidemiology of tuberculosis among SARS CoV-2 pandemics.

54.

Exploration into the potential sources of Mucorales in a dedicated COVID-19 treatment centre (NCI)

55.

Regional Virus Research and Diagnostic Laboratory (RL-VRDL)

56.

NACO Regional Reference Laboratory for HIV viral load (VL) and early infant diagnosis (EID)

57.

National Vector Borne Disease Control Programme Apex Laboratory for Dengue and Chikungunya

58.

National Viral Hepatitis Control Program Surveillance laboratory

59.

Whole genome sequencing of the SARS-CoV-2 novel coronavirus strains at a tertiary care center in Delhi.

60.

Human cytomegalovirus disease in pediatric hematological malignancies

61.

Molecular detection of viral pathogens causing non-gonococcal urethritis (NGU)

62.

A prospective study of viral infections in hematopoietic  stem cell transplant recipients at a tertiary care hospital in India

63.

Detection and genotyping of BK polyomavirus in renal transplant recipients

64.

Expanded viral etiological investigation of genital ulcer disease with phenotyping and genotyping for antiviral drug resistance in herpes simplex viruses

 

 

 

 

 

Zo2 Framework Settings

Select one of sample color schemes

Google Font

Menu Font
Body Font
Heading Font

Body

Background Color
Text Color
Link Color
Background Image

Header Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Menu Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Main Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Inset Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Bottom Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image
Background Color
Modules Title
Text Color
Link Color
Background Image
 
Top of Page
BCMath lib not installed. RSA encryption unavailable